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107 bacterial isolates with Gram positive staining and negative catalase activity,
presumably assumed as lactic acid bacteria, were isolated from samples of meconium
of 6 donors at Roubaix hospital, in the north of France. All these bacterial isolates were
identified by MALDI-TOF mass spectrometry as Enterococcus faecalis. However, only
six isolates among which E. faecalis 14, E. faecalis 28, E. faecalis 90, E. faecalis 97,
and E. faecalis 101 (obtained from donor 3), and E. faecalis 93 (obtained from donor 5)
were active against some Gram-negative bacteria and Gram-positive bacteria, through
production of lactic acid, and bacteriocin like inhibitory substances. The identification
of these isolates was confirmed by 16rDNA sequencing and their genetic relatedness
was established by REP-PCR and pulsed field gel electrophoresis methods. Importantly,
the aforementioned antagonistic isolates were sensitive to various classes of antibiotics
tested, exhibited high scores of coaggregation and hydrophobicity, and were not
hemolytic. Taken together, these properties render these strains as potential candidates
for probiotic applications.
Keywords: meconium, Enterococcus faecalis, antagonism, anti-Staphylococcus activity, enterocins
Introduction
Human microbiome is undergoing dynamic changes in bacterial content in the gut during preg-
nancy and development of childhood (Dominguez-Bello et al., 2010). In early childhood, the
presence of pathogenic species, or absence of beneﬁcial ones, leads to adverse eﬀects such as initia-
tion of preterm birth (DiGiulio et al., 2008), and development of asthma, allergy, and autism (Hong
et al., 2010; Johansson et al., 2011; Wang et al., 2011). Microbes colonizing the gastrointestinal tract
of the infant are originated from the mother and surrounding environment during the birth and
shortly thereafter (Mshvildadze et al., 2010). The fetus, as well as the intrauterine environment,
have been considered sterile, but the presence of microbes was reported in amniotic ﬂuid (Hitti
et al., 1987), fetal membranes (Steel et al., 2005), and meconium (Gosalbes et al., 2013). Meconium
is the ﬁrst intestinal discharge of newborns, which consists of a viscous, sticky, dark green sub-
stance. It might contain materials ingested during time that the infant has spent in the uterus;
these could include epithelial cells, mucus, bile acid, blood, lanugo, and amniotic ﬂuid (Cleary
and Wiswell, 1998; Gosalbes et al., 2013). Newborns seem to acquire their ﬁrst microbiota at birth
andmaternal vaginal or skin bacteria colonize newborns delivered vaginally or by caesarian section
(C-section; Alicea-Serrano et al., 2013). Hu et al. (2013) conﬁrmed that meconium is not sterile and
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does contain diversiﬁedmicrobiota. Moles et al. (2013) character-
ized the microbiota from meconium and fecal samples obtained
during the ﬁrst 3 weeks of life from 14 donors. They showed
that bacilli and other Firmicutes were important in meconium
whilst Proteobacteria dominated in the fecal samples based on
molecular method. Staphylococcus predominated in meconium
while Enterococcus and Gram-negative bacteria (GNB) were
more abundant in fecal samples (Moles et al., 2013). Makino
et al. (2013) showed that several Bifidobacterium strains transmit-
ted from the mother are colonizing the infant’s intestine shortly
after birth. Thus, the gut of infant might contain diﬀerent species
such as Enterococci, Biﬁdobacteria, and Lactobacilli that protect
mucus of infants from pathogenic species through production
of inhibitory substances including hydrogen peroxide, organic
acids, and bacteriocins (Vizoso-Pinto et al., 2006; Rodríguez
et al., 2012). Enterococci, particularly Enterococcus faecalis and
E. faecium are involved in the reduction or prevention of gas-
tro intestinal tract infections (Franz et al., 2011). Enterococci
belong to the group of LAB, which is known to produce lactic
acid as the end product of sugar fermentation, and antimicro-
bials, which are active against pathogens including Staphylococcus
aureus and Listeria monocytogenes (Campos et al., 2006). Further,
many strains of E. faecalis produce bacteriocins named ente-
rocins, a family of safe (Belguesmia et al., 2011), and ribosomally
synthesized antimicrobial peptides (AMP; Drider and Rebuﬀat,
2011). This study aimed at studying and taking advantage of the
LAB isolated from meconium sampled at Roubaix hospital in the
North of France.
Materials and Methods
Preparation of Samples, Isolation, and
Identification of Lactic acid Bacteria
Samples of fresh meconium were collected, in sterile dry plastic
containers, from 6 donors (newborn infants), at Roubaix hospi-
tal in the North of France. Samples of meconium were stored at
4◦C until to be processed. One gram of meconium was resus-
pended in 9 ml of 0.9% (w/v) of sterile saline solution, and was
serially diluted from 10−1 to 10−6. One ml of each dilution was
poured onto Petri dishes and melt MRS (de Man-Rogosa-Sharpe)
agar medium (Biokar, France; de Man et al., 1960) was poured
gently. After agar solidiﬁcation at room temperature, plates were
incubated under 5% CO2 at 37◦C for 24–48 h. The grown
colonies were Gram-stained and checked for catalase activity.
Presumptive LAB strains were selected, maintained at −80◦C
in MRS with 25% glycerol as stock culture, until use. The pre-
sumptive LAB isolates were identiﬁed by the VITEK MS v2.0
MALDI-TOF mass spectrometry according to manufacturer’s
instructions.
Antimicrobial Activity
The antibacterial activity was assessed against the GNB and
Gram-positive bacteria (GPB) listed in Table 1, using the well
known agar diﬀusion test (Naghmouchi et al., 2006). The cell free
supernatants (CFS) used for antibacterial activity measurement
were obtained by centrifuging (9000 × g, 10 min, 4◦C), overnight
cultures of E. faecalis grown at 37◦C for 18–24 h, on MRS broth.
Wells were performed in solid agar and 50μl of each CFS or neu-
tralized cell-free supernatant (NCFS; pH6.5) were poured into the
wells. The Petri plates were left at room temperature, in sterile
conditions, for 1 h before incubation for 18 h at adequate tem-
perature. After this period of incubation, the antibacterial activity
was detected by observing the inhibition zones around the well
containing the CFS or NCFS. Importantly, the impacts of temper-
ature and pH variations as well as proteinase K, papain, trypsin,
and α-chymotrypsin at 1 mg/ml (Sigma-Aldrich Germany) were
determined toward Listeria innocua CIP 103982.
Molecular Characterization of the
Antagonistic Isolates
Total DNA was extracted from each antagonistic isolates using
Wizard R© Genomic DNA Puriﬁcation Kit (Promega, Madison,
WI, USA). For 16S rDNA analysis, total DNA was ampli-
ﬁed with 16S forward 5′-AGAGTTTGATCMTGGCTCAG-3′
and 16S reverse 5′-GGMTACCTTGTTACGAYTTC-3′ primers
(Drago et al., 2011), and the following PCR program: 94◦C/3min,
29 cycles at 94◦C/40 s, 55◦C/50 s and 72◦C/2 min; and ﬁnally
72◦C/10 min. For REP-PCR analysis, total DNA was ampli-
ﬁed with 5′- (GTG)5−3 primer and the following program:
95◦C/5 min, 30 cycles at 94◦C/1 min, 40◦C/1 min, 72◦C/8 min,
and ﬁnally 72◦C/16 min. Amplicons were separated on 1%
agarose gel. Electrophoresis was performed at 100 V for 2 h
using 1X Tris-borate-EDTA. The gels were stained with GEL-
RED (Biotium, Canada), and visualized by GelDoc (Bio-Rad,
France). Dendrograms were generated automatically using the
DIVERSILAB R© software (Biomérieux, Craponne, France).
The amplicons for 16S rDNAswere puriﬁed with the pJET1Kit
(Fermentas, France), and sequenced at Euroﬁns MWG Operon
(Germany). Partial 16S rDNAs sequences were compared to that
of E. faecalis ATCC 19433 using ClustalW2 software1.
Challenge Tests: Staphylococcus aureus
ATCC 33862 vs. Antagonistic E. faecalis
Enterococcus faecalis was grown in MRS and S. aureus
ATCC33862 in Brain Heart Infusion (BHI; 105 CFU/ml) at 37◦C
for 18 h. After this period, the cultures had reached 108 CFU/ml
for E. faecalis, and 105 CFU/ml for S. aureus ATCC33862.
Afterward, 0.1 ml of each culture was added to 20 ml of BHI con-
taining leading to 5. 105 CFU/ml (E. faecalis) and 5. 102 CFU/ml
(S. aureus ATCC33862). One ml of this coculture was withdrawn
at 0, 4, 8, 12, 18, and 24 h, and was serially diluted from 10−1 to
10−6, in 0.9% (w/v) of saline water. Then 1 ml of each dilution
was plated on Plates dishes containing MRS agar for E. faecalis,
and Chapman agar for S. aureus ATCC33862. The number of
colonies was determined after 24 h of incubation at 37◦C.
Lactic Acid Quantification
Lactic acid was quantiﬁed by HPLC spectra system P1000XR
(Thermo, USA). Isolates E. faecalis 28 and E. faecalis 93 were
grown in MRS broth at 37◦C, samples were withdrawn after 0,
4, 8, 12, 18, and 24 h of incubation, centrifuged (10,000 ×x g,
1http://www.ebi.ac.uk/Tools/msa/clustalw2/
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10 min, 4◦C), and sterilized by ﬁltration using Millipore ﬁlter
(0.2 μm). The CFS were divided into 3 samples. Sample 1 was
used to measure pH, sample 2 to assess the antibacterial activ-
ity against S. aureus ATCC33862 by the well diﬀusion method
(Naghmouchi et al., 2006), and sample 3 to determine the con-
centration of lactic acid. All these experiments were performed in
triplicate.
Autoaggregation Assay
Autoaggregation assays were performed according to initial pro-
tocol of Del Re et al. (2000) and modiﬁed by Al Kassaa et al.
(2014). Thus, isolates of interest were cultured on MRS for 18 h
at 37◦C, then cells were centrifuged (5,000 × g, 4◦C, 15 min),
washed three times with phosphate saline (PBS) buﬀer (pH7.0)
and were resuspended in sterile PBS to obtain a viable cell count
of 108 CFU/ml. The bacterial suspension of 4 ml was mixed by
vortexing for 10 s and incubated at room temperature for diﬀer-
ent time intervals (0, 1, 2, 3, 4, or 5 h). At each interval, the growth
was measured at OD600 nm. The percentage of autoaggregation
was expressed as follows:
% autoaggregation = [(OD1 − OD2)/(OD1)] × 100.
Where OD1 represents the optical density at time (1, 2, 3, 4,
or 5 h) and OD2 the data at time 0 h. All experiments were
performed in triplicate.
Hydrophobicity
The hydrophobicity was determined using in vitro method to
detect the bacterial adhesion to hydrocarbons (Rosenberg et al.,
1980). Each antagonistic LAB isolate was grown in MRS broth
at 37◦C for 18 h. The bacterial cells harvested by centrifugation
(5,000 × g, 4◦C, 15 min) were washed twice with PBS (pH7.0),
resuspended in the same solution and the OD600 nm was deter-
mined. One milliliter of xylene (Fluka, Germany) was added
to 3 ml of cell suspension and vortexed for 2 min after 10 min
of incubation at room temperature. The aqueous phase was
removed after 2 h of incubation at room temperature and the
OD600 nm was determined. The percentage of hydrophobicity
was calculated using the formula given below. All experiments
were performed in triplicate.
% hydrophobicity = [(OD600 nm reading 1 − OD600 nm reading
2)/OD600 nm reading 1] × 100.
Hemolytic Activity
The hemolytic activity was determined by streaking Enterococcal
isolates on Columbia blood agar supplemented with 5% (v/v)
of human blood or Sheep blood. The plates were incubated at
37◦C for 48 h. The presence or absence of zones of clearing
around the colonies was interpreted as β-hemolysis (positive
hemolytic activity) or χ-hemolysis (negative hemolytic activ-
ity), respectively. When observed, greenish zones around the
colonies were interpreted as α-hemolysis and taken as nega-
tive for the assessment of hemolytic activity (Semedo et al.,
2003).
Antimicrobial Susceptibility
Study of antibiotic susceptibility was performed by three inde-
pendent methods: disk diﬀusion method, minimal inhibitory
concentrations (MICs) using E test (Bio-Mérieux, France), and
VITEK 2 system (Bio-Mérieux, France). Related to this, AST-
P606 card was used for “Enterococci” encompassing nearly
all important antibiotics among which ampicillin, gentam-
icin, kanamycin, streptomycin, levoﬂoxacin, moxiﬂoxacin, ery-
thromycin, clindamycin, linezolid, teicoplanin, vancomycin,
tetracycline, nitrofurantoin chloramphenicoland trimethoprim-
sulfamethoxazole. Antibiotic susceptibility and MICs were deter-
mined and analyzed according to the French Committee on
Antimicrobial Susceptibility Testing (CA-SFM 2013).
Results
Scavenging of Lactic Acid Bacteria and
Elucidation of their Antagonism
Hundred and seven LAB isolates were isolated from 6 samples
of meconium newborns infants (6 donors) obtained at Roubaix
hospital in the North of France. The number of LAB isolates
per sample of meconium/donor was as follows: sample 1 (20
LAB isolates), sample 2 (12 LAB isolates), sample 3 (LAB 26 iso-
lates), sample 4 (LAB 12 isolates), sample 5 (LAB 17 isolates),
and sample 6 (LAB 20 isolates). In addition to their Gram pos-
itive staining, and absence of catalase activity, all these 107 LAB
isolates were able to hydrolyze esculine. Importantly, all of them
were identiﬁed by MALDI TOF mass spectrometry (Biomérieux,
France), with high score (>99%), as E. faecalis. Among these
E. faecalis species, only six isolates designed as E. faecalis 14, E.
faecalis 28, E. faecalis 90, E. faecalis 93, E. faecalis 97, and E. fae-
calis 101 resulted to be antagonistic. Partial 16S ribosomal DNA
sequences of these isolates as well as those of E. faecalis ATCC
19433 were aligned using ClustalW2 software2. This alignment
shows a percentage of similarity higher than 99.7% to E. faecalis,
conﬁrming phylogenetic identiﬁcation of our isolates. When the
16S rDNA sequence of E. coli ATCC 11229 was compared to
that of enterococci, the percentage of similarity was estimated
to 76.33%, which clearly is very low. These antagonistic isolates
were able to produce lactic acid and bacteriocin like inhibitory
substances (BLIS) and consequently to inhibit growth of GNB
and GPB (Table 1). This antagonism was restricted to GPB when
the pH of CFS was adjusted to 6.5 (Table 1). The BLIS produced
by the aforementioned antagonistic strains resulted to be insensi-
tive to pH and temperature variations but sensitive to proteases.
Remarkably, only E. faecalis 90 and E. faecalis 101 were active
against Pseudomonas fluorescens (Table 1).
Genetic Patterns of the Antagonistic Strains
Genetic patters gathered by REP-PCR permitted to create two
main groups. Indeed, group 1 contains isolates E. faecalis 14,
E. faecalis 28, E. faecalis 90, E. faecalis 97, and E. faecalis 101,
whereas group 2 contains only isolate E. faecalis 93 (Figure 1).
Based on their genetic patterns and analysis of the dendrogram
2http://www.ebi.ac.uk/Tools/msa/clustalw2/
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FIGURE 1 | Genetic relatedness of antagonistic strains. (A) REP-PCR
products were separated on 1% agarose gel. Lane M corresponds to
the DNA markers (Thermo, USA), lane C corresponds to the PCR
control (PCR carried without DNA template), lanes 1, 2, 3, 4, 5, 6
correspond to genetic patterns of Enterococcus faecalis 14 (Ef14),
E. faecalis 28 (Ef28), E. faecalis 90 (Ef90), E. faecalis 93 (Ef93),
E. faecalis 97 (Ef97), and E. faecalis 101 (Ef101). (B) Dendrogram
outlining Pearson correlation of antagonistic E. faecalis 14 (Ef14),
E. faecalis 28 (Ef28), E. faecalis 90 (Ef90), E. faecalis 93 (Ef93),
E. faecalis 97 (Ef97) and E. faecalis 101 (Ef101).
FIGURE 2 | Interplay between Staphylococcus aureus ATC C33862 and
enterococci during coculture. Samples were withdrawn at regular intervals
of time and plated onto agar Brain Heart for counting of S. aureus and on
agar MRS for counting of enterococci E. faecalis 28 (A), E. faecalis 93 (B),
and E. faecalis ATCC 29212 (C). The values expressed in Log CFUT ml−1
(±SD) are the average of at least three independent experiments.
and pulsed ﬁeld gel electrophoresis (PFGE; data not shown here),
we assume that E. faecalis 14 and E. faecalis 28, then E. faecalis 90
and E. faecalis 93, E. faecalis 97 and E. faecalis 101 have similar
DNA patterns.
Highlights on Anti-S. aureus ATCC33862
Activity
The data gathered from the challenge tests indicate that inhibition
of S. aureus ATCC 33862 by E. faecalis 28 and E. faecalis 93 was
due to production of lactic acid and bacteriocin. The number of
S. aureus ATCC33862 cells has decreased of about 5.5 Log, 5 Log,
and 2 log in presence of E. faecalis 28, E. faecalis 93, and E. faecalis
ATCC29212 (Figures 2A–C).
Production of Lactic Acid and Bacteriocins
like Inhibitory Substances
Enterococcus faecalis 28 and E. faecalis 93 isolates produced
up to 7.06 g/l of lactic acid, after 24 h of culture. As shown
on Figures 3A,B, the drop of pH observed during coculture,
was correlated to increase of lactic acid production. The anti-
staphylococcal activity was ascribed to both lactic acid and bac-
teriocins, and this activity appeared to increase until 18 h of
co-culture.
Cell Surface Properties of the Antagonistic
Isolates
Table 2 shows the scores of hydrophobicity and autoaggregation
of antagonistic isolates. The highest scores were registered for
E. faecalis 14; that was isolated from donor 3.
Antagonistic Strains are Sensitive to
Antibiotics and are Not Hemolytic
As indicated in Tables 3A,B, antagonistic strains are sensitive
to antibiotics tested. To be noted that E. faecalis 14 and E. fae-
calis 93 are resistant to erythromycin, whilst isolates E. faecalis
28, E. faecalis 90, E. faecalis 97, and E. faecalis 101 exhibit inter-
mediate resistance to this drug. Further, all antagonistic isolates
are sensitive to ampicillin, gentamicin, kanamycin, streptomycin,
levoﬂoxacin, moxiﬂoxacin, linezolid, teicoplanin, vancomycin,
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FIGURE 3 | Measurement of pHs, amount of lactic acid (g L−1) and inhibitory activity of the cell free supernatants (CFS) prepared from E. faecalis 28
(A) and E. faecalis 93 (B) after different times of growth. The data are the average of at least three independent experiments.
TABLE 2 | Autoaggregation and hydrophobicity percentages of
antagonistic meconium enterococci.
Isolates Autoaggregation (%) Hydrophobicity (%)
E. faecalis 14 49 ± 0.47 47 ± 0.8
E. faecalis 28 44 ± 1.6 45.6 ± 0.47
E. faecalis 90 35 ± 1.24 41 ± 1.2
E. faecalis 93 44.6 ± 1.8 46.3 ± 1.2
E. faecalis 97 41 ± 1.24 34 ± 1.4
E. faecalis 101 45 ± 1.6 43 ± 0.94
E. faecalis ATCC29212 45.6 ± 0.1.2 42.3 ± 0.9
tetracycline, nitrofurantoin, and chloramphenicol but are resis-
tant to clindamycin and trimethoprim-sulfamethoxazole. The
data analysis was performed according to “Antibiogram commit-
tee of French Microbiology of Society” based on the European
Committee on Antimicrobial Susceptibility Testing recommen-
dations. Remarkably, these strains were not hemolytic (data not
shown).
Accession Numbers
The accession numbers were KP057871 (E. faecalis 14), KP057872
(E. faecalis 28), KP057873 (E. faecalis 90), KP057874 (E. fae-
calis 93), KP057875 (E. faecalis 97), KP057876 (E. faecalis
101), NR_115765.1 (E. faecalis ATCC 19433), and GQ340751.1
Escherichia coli ATCC 11229.
Discussion
This study aimed at strictly isolating LAB and particularly bac-
teriocinogenic LAB from meconium of newborns infants. Thus,
107 bacterial isolates were obtained from meconium of 6 donors
at Roubaix Hospital in the north of France. All the bacterial iso-
lates were identiﬁed as E. faecalis. Interestingly, Borderon et al.
(1996), Adlerberth et al. (2006) showed that E. faecalis colonizes
the gut of vaginally and cesarean-delivered term and preterm
neonates Clinical isolates of enterococci are weakly diverse com-
paratively to those obtained from the environment, but E. faecalis
remains the dominant species (Kuhn et al., 2003). According to
Fisher and Phillips (2009), this weak diversity could be linked to
the virulence factors present in this species.
Isolates E. faecalis 14, E. faecalis 28, E. faecalis 90, E. faecalis 93,
E. faecalis 97, and E. faecalis 101 produce inhibitory compounds
that comprise lactic acid and BLIS. The concomitant production
of these antimicrobials inhibited a set of GNB and GPB, including
the robust methicillin-resistant S. aureus (MRSA), which is fre-
quently encountered in hospital environment. Remarkably, this
antagonism was abolished when the CFS was neutralized, high-
lighting thereof the role of BLIS. Vancomycin is the standard
antibiotic used for the treatment of MRSA infections. Recently,
Liang et al. (2014), suggested daptomycin as a reasonable alter-
native for treating MRSA mainly for osteoarticular infections
(OAIs). The activity of these antibiotics could be potential-
ized with bacteriocins, which are overall safe (Belguesmia et al.,
2011), ribosomally synthesized AMP (Drider and Rebuﬀat, 2011).
Genotyping of these isolates performed by REP-PCR and PFGE
(data not shown) concluded to three diﬀerent strains. Percent
Identity Matrix based on 16S ribosomal DNA conﬁrms a high
score of similarity of enterococci sequences and a low score of
similarity with E. coli ATCC 11229 used as diﬀerent bacterial
taxon.
In this study, E. faecalis 28 and E. faecalis 93, obtained from
two diﬀerent sources, were the most actives isolates. In their
presence, the counts of S. aureus ATCC33862 has drastically
decreased. Further, the antagonistic isolates displayed high scores
of autoaggregation and hydrophobicity. These two characteris-
tics might be important for the interplay of these isolates with
S. aureus ATCC33862. Clewell et al. (2002) reported that pro-
duction of aggregation substance (Agg) on the donor cell-surface
facilitates contact with recipient cell by binding to enterococcal
binding substance.
Importantly, these antagonistic strains were not hemolytic
and resulted to be sensitive to antibiotic usually used to
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TABLE 3A | Antibiotic susceptibility of antagonistic isolates.
Antibiotics MIC: mg/l E. faecalis 14 E. faecalis 28 E. faecalis 90 E. faecalis 93 E. faecalis 97 E. faecalis 101
Ampicillin S ( ≤ 2) S ( ≤ 2) S ( ≤ 2) S ( ≤ 2) S ( ≤ 2) S ( ≤ 2)
Gentamicin (high level) S S S S S S
Kanamycin (high level) S S S S S S
Streptomycin (high level) S S S S S S
Levofloxacin S (1) S (1) S (1) S (1) S (1) S (1)
Moxifloxacin S ( ≤ 0.25) S ( ≤ 0.25) S ( ≤ 0.25) S ( ≤ 0.25) S ( ≤ 0.25) S ( ≤ 0.25)
Clindamycin R ( ≥ 8) R ( ≥ 8) R ( ≥ 8) R ( ≥ 8) R ( ≥ 8) R ( ≥ 8)
Linezolid S (2) S (2) S (2) S (2) S (2) S (2)
Teicoplanin S ( ≤ 0.5) S ( ≤ 0.5) S ( ≤ 0.5) S ( ≤ 0.5) S ( ≤ 0.5) S ( ≤ 0.5)
Vancomycin S (1) S (1) S (1) S (2) S (1) S (2)
Tetracyclin S ( ≤ 1) S ( ≤ 1) S ( ≤ 1) S ( ≤ 1) S ( ≤ 1) S ( ≤ 1)
Nitrofurantoin S ( ≤ 16) S ( ≤ 16) S ( ≤ 16) S ( ≤ 16) S ( ≤ 16) S ( ≤ 16)
Chloramphenicol S (8) S (8) S (8) S (8) S (8) S (8)
Trimethoprime/sulfamethoxzole S ( ≤ 10) S ( ≤ 10) S ( ≤ 10) S ( ≤ 10) S ( ≤ 10) S ( ≤ 10)
Erythromycin R ( ≥ 8) I (4) I (4) R ( ≥ 8) I (4) I (4)
R, Resistant; S, Sensitive; I, Intermediate; MIC, Minimal inhibitory concentration determined by Vitek 2 system.
TABLE 3B | Antibiotic susceptibility of antagonistic isolates.
Antibiotics MIC: mg/l E. faecalis 14 E. faecalis 28 E. faecalis 90 E. faecalis 93 E. faecalis 97 E. faecalis 101
Ampicillin S (0.75) S (0.75) S (0.75) S (0.75) S (0.38) S (0.38)
Gentamicin (high level) S S S S S S
Kanamycin (high level) S S S S S S
Streptomycin (high level) S S S S S S
Levofloxacin S (1) S (1) S (1) S (1) S (1) S (1)
Moxifloxacin S S S S S S
Clindamycin R R R R R R
Linezolid S (2) S (1) S (1) S (1.5) S (1.5) S (2)
Teicoplanin S (0.25) S (0.25) S (0.25) S (0.25) S (0.25) S (0.25)
Vancomycin S (2) S (1) S (1) S (1) S (2) S (2)
Tetracyclin S S S S S S
Nitrofurantoin S S S S S S
Chloramphenicol S S S S S S
Trimethoprime/sulfamethoxzole S S S S S S
Erythromycin R (2) I (2) I (1) R (1.5) I (1) I (1.5)
R, Resistant; S, Sensitive; I, Intermediate determined by Vitek 2; MIC, Minimal inhibitory concentration determined by E test.
treat enterococci infections. The resistance to clindamycin and
Trimethoprime/sulfamethoxzole is thought to be a species char-
acteristic. According to the opinion of the FEEDAP panel on the
updating of criteria used in the assessment of bacteria for resis-
tance to antibiotics of human and veterinary importance, strains
carrying an acquired resistance to antimicrobial(s) should not
be used as feed additives, unless it can be demonstrated that it
is a result of chromosomal mutation(s) (European Food Safety
Authority [EFSA], 2005).
This study unveiled the presence of only E. faecalis species in
samples of meconium obtained from six donors at Roubaix hos-
pital in the north of France. Oﬀ 107 E. faecalis isolates, only E.
faecalis 14, E. faecalis 28, E. faecalis 90, E. faecalis 93, E. faecalis
97, and E. faecalis 101 resulted to be bacteriocinogenic. In the
best of our knowledge, this is the ﬁrst report dealing with bacte-
riocinogenic LAB from meconium. The number of antagonistic
isolates is relatively low (5.60%) compared to the frequency
usually reported in the literature (Nes et al., 2014). The high
hydrophobicity and aggregation scores registered for the afore-
mentioned antagonistic isolates, as well as absence of hemolytic
activity and sensibility to various antibiotic render these strains
as potential candidates for probiotic applications.
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